share_log

USANA Health Sciences Announces Strategic Acquisition of Hiya Health

USANA Health Sciences Announces Strategic Acquisition of Hiya Health

优莎娜健康科学宣布战略收购Hiya Health
优莎娜 ·  12/23 13:00

USANA Health Sciences Announces Strategic Acquisition of Hiya Health

USANA 健康科学宣布战略收购 Hiya Health

Download as PDFDecember 23, 2024

以 PDF 格式下载 2024 年 12 月 23 日

Hiya is a fast-growing, emerging leader of high-quality children's health & wellness products.

Hiya是高品质儿童健康与保健产品的快速成长的新兴领导者。

Broadens USANA's reach into the highly attractive direct-to-consumer channel driven by Hiya's powerful subscription model with runway for sustainable future growth.

在Hiya强大的订阅模式的推动下,将USANA的影响范围扩大到极具吸引力的直接面向消费者的渠道,为未来的可持续增长铺平了道路。

Expected to be immediately accretive to 2025 adjusted EBITDA.

预计将立即增加到2025年调整后的息税折旧摊销前利润。

9/30/2024 LTM net sales of $103 million, LTM net income of $19 million, and LTM adjusted EBITDA of $22 million.

2024年9月30日LtM净销售额为1.03亿美元,LtM净收入为1900万美元,LtM调整后的息税折旧摊销前利润为2200万美元。

The Company will discuss the transaction during a conference call on Monday, December 23, 2024, at 5:00 PM ET.

该公司将在美国东部时间2024年12月23日星期一下午5点的电话会议上讨论该交易。

SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE: USNA) (the "Company," "USANA"), today announced its acquisition of a 78.8% controlling ownership stake in Hiya Health Products, LLC ("Hiya"), a leading direct-to-consumer provider of high-quality children's health & wellness products. The $205 million cash transaction closed on December 23, 2024 and is anticipated to be accretive to USANA's 2025 adjusted EBITDA. For the last twelve months ended September 30, 2024 (unaudited), Hiya generated net sales of $103 million, net income of $19 million, and adjusted EBITDA of $22 million. As of September 30, 2024, Hiya had more than 200,000 customers.

盐湖城--(美国商业资讯)--USANA Health Sciences, Inc.(纽约证券交易所代码:USNA)(“公司”,“USANA”)今天宣布收购领先的高品质儿童健康与保健产品供应商Hiya Health Products, LLC(“Hiya”)78.8%的控股权。这笔2.05亿美元的现金交易于2024年12月23日完成,预计将增加USANA2025年调整后的息税折旧摊销前利润。在截至2024年9月30日的最后十二个月中(未经审计),Hiya的净销售额为1.03亿美元,净收入为1,900万美元,调整后的息税折旧摊销前利润为2,200万美元。截至 2024 年 9 月 30 日,Hiya 拥有超过 200,000 名客户。

"The Hiya brand is a natural fit for USANA and this acquisition represents a key strategic milestone for our business," said Jim Brown, President and Chief Executive Officer of USANA Health Sciences, Inc. "Hiya's co-founders, Darren Litt and Adam Gillman, have disrupted the children's health and wellness market by building a high quality, better-for-you brand that aligns with our vision of creating the healthiest family on Earth. This strategic acquisition adds a diversified layer of growth to USANA's overall business, while maintaining our commitment to our core direct sales business, where we continue to invest in initiatives to drive growth. Notably, this acquisition will allow USANA to reach a broader audience by diversifying distribution channels through Hiya, which we believe will enhance our ability to generate sustainable long-term growth and deliver value for our stakeholders. Darren and Adam will continue to lead Hiya through its next phase of growth. Their leadership and expertise is instrumental to Hiya's business, which is now part of USANA's mission and strategic objectives."

USANA健康科学公司总裁兼首席执行官吉姆·布朗说:“Hiya品牌天生适合USANA,此次收购是我们业务的关键战略里程碑,” USANA健康科学公司总裁兼首席执行官吉姆·布朗说,“Hiya的联合创始人达伦·利特和亚当·吉尔曼通过建立一个高质量、更适合您的品牌,颠覆了儿童健康和保健市场,该品牌符合我们创建地球上最健康家庭的愿景。此次战略收购为USANA的整体业务增加了多元化的增长层,同时维持了我们对核心直销业务的承诺,我们将继续投资于推动增长的举措。值得注意的是,此次收购将使USANA能够通过Hiya实现分销渠道的多元化,从而吸引更广泛的受众,我们相信这将增强我们实现可持续长期增长并为利益相关者创造价值的能力。达伦和亚当将继续带领Hiya进入下一阶段的增长。他们的领导能力和专业知识对Hiya的业务至关重要,而Hiya的业务现已成为USANA使命和战略目标的一部分。”

Darren Litt, co-founder and CEO of Hiya, commented, "Today represents an exciting chapter for Hiya and we are thrilled to join the USANA family. As parents ourselves, we recognized that so many wellness companies did not prioritize our children's health interests, so we created Hiya to give families the very best in clean, honest nutrition. With the help of USANA's extensive capabilities, support and international expertise, we can now extend that commitment to create healthy products for more families in more countries. USANA and Hiya share a deep commitment to improving the lives of families everywhere by providing the best nutritional products possible, and we look forward to continuing this exciting journey as part of USANA."

Hiya联合创始人兼首席执行官达伦·利特评论说:“今天对Hiya来说是一个激动人心的篇章,我们很高兴加入USANA大家庭。作为父母,我们意识到许多健康公司并未优先考虑孩子的健康利益,因此我们创立了Hiya,旨在为家庭提供最好的清洁、诚实的营养。在USANA广泛的能力、支持和国际专业知识的帮助下,我们现在可以扩大这一承诺,为更多国家的更多家庭生产健康的产品。USANA和Hiya共同坚定地致力于通过提供最好的营养产品来改善世界各地家庭的生活,我们期待作为USANA的一部分继续这一激动人心的旅程。”

Strategic Rationale

战略理由

  • Fast-Growing, Emerging Leader in the Children's Health and Wellness Market. The acquisition of Hiya provides the opportunity for USANA to expand its presence in the children's health & wellness market through Hiya. For the last twelve months ended September 30, 2024, Hiya's net sales of $103 million grew 50% as compared to fiscal year 2023. For fiscal year 2025, the Company currently anticipates Hiya's net sales growth to approach 30% year-over-year.

  • Strengthens USANA's Financial Profile. Hiya offers a compelling subscription model with attractive margins, profitability, and cash flow generation, which is expected to enhance the Company's ability to deliver long-term growth and drive shareholder value. Hiya's domestic profitability diversifies USANA's geographic sales mix and is anticipated to lower the Company's consolidated effective tax rate and create a more tax-efficient structure.

  • Presents Opportunity to Accelerate Growth and Enhance Profitability by Leveraging Synergies. Over the next several years, USANA and Hiya will work together to take advantage of identified synergies, assets and expertise across both companies to create efficiencies, and to accelerate growth and profitability. For example, there are opportunities for Hiya to leverage USANA's significant manufacturing and international expansion expertise. Similarly, USANA may leverage Hiya's market data insights, marketing expertise, and children-focused products within its direct sales channel.

  • Channel Expansion into Direct-to-Consumer Wellness Market with a Leading and Proven Brand. Hiya currently holds a leading position in children's Vitamins, Minerals & Supplements brand sales in the United Statesi and has a clear pathway and strong growth strategy to become the #1 children's wellness platform through new product introductions, channel expansion, and geographic expansion. Hiya's commitment to being the most trusted and preferred brand for wellness products in the 0-18 age range is an additive category for the Company and is complimentary to USANA's vision of the healthiest family on Earth.

  • Expands the Company's United States Operations. The transaction meaningfully expands and diversifies the Company's revenue mix as Hiya's net sales are generated in the United States through their direct-to-consumer subscription model, with plans to enter other sales channels. This will allow USANA to reach a broader audience of health-conscious consumers to grow the enterprise's overall customer base.

  • 快速成长的儿童健康和保健市场的新兴领导者。收购Hiya为USANA提供了通过Hiya扩大其在儿童健康与保健市场的影响力的机会。在截至2024年9月30日的最后十二个月中,Hiya的净销售额为1.03亿美元,与2023财年相比增长了50%。该公司目前预计,对于2025财年,Hiya的净销售额同比增长将接近30%。

  • 强化USANA的财务状况。Hiya提供引人注目的订阅模式,具有诱人的利润率、盈利能力和现金流产生,预计这将增强公司实现长期增长和推动股东价值的能力。Hiya的国内盈利能力使USANA的地域销售结构多样化,预计将降低该公司的合并有效税率并创造更具税收效率的结构。

  • 通过利用协同效应为加速增长和提高盈利能力提供了机会。在未来几年中,USANA和Hiya将共同努力,利用两家公司已确定的协同效应、资产和专业知识来提高效率,加速增长和盈利。例如,Hiya有机会利用USANA丰富的制造和国际扩张专业知识。同样,USANA可能会在其直销渠道中利用Hiya的市场数据洞察力、营销专业知识和以儿童为中心的产品。

  • 凭借领先和久经考验的品牌,将渠道扩展到直接面向消费者的健康市场。Hiya目前在美国的儿童维生素、矿物质和补充剂品牌销售方面处于领先地位,并有明确的路径和强劲的增长战略,通过新产品推出、渠道扩展和地域扩张成为 #1 儿童健康平台。Hiya致力于成为0-18岁年龄段健康产品中最值得信赖和首选的品牌,这是公司的附加类别,也符合USANA对地球上最健康家庭的愿景。

  • 扩大公司在美国的业务。该交易有意义地扩大了公司的收入结构并使其多样化,因为Hiya的净销售额是通过其直接面向消费者的订阅模式在美国产生的,并计划进入其他销售渠道。这将使USANA能够吸引更广泛的注重健康的消费者,以扩大企业的整体客户群。

i Source: Nielsen

i 来源:尼尔森

Transaction Highlights

交易亮点

  • The Company made an initial cash investment of approximately $205 million (subject to customary closing and post-closing purchase price adjustments) in exchange for a 78.8% ownership stake in Hiya.

  • Transaction structure includes a put/call feature that provides for USANA's acquisition of the remaining rollover equity at a pre-negotiated valuation scale, which is based on Hiya's financial performance.

  • The transaction was financed with $200 million cash on hand with the balance covered by the Company's existing credit facility.

  • 该公司进行了约2.05亿美元的初始现金投资(视惯例成交和收盘后的收购价格调整而定),以换取Hiya78.8%的所有权。

  • 交易结构包括看跌/看涨期权功能,规定USANA根据Hiya的财务业绩,按照预先商定的估值规模收购剩余的展期股权。

  • 该交易由2亿美元的手头现金融资,余额由公司现有的信贷额度支付。

BofA Securities acted as exclusive financial advisor to the Company in connection with the transaction. Wilson Sonsini Goodrich & Rosati, P.C. served as the Company's legal advisor. William Hood & Company, LLC acted as exclusive financial advisor to Hiya. Bodman PLC acted as Hiya's legal advisor.

美银证券担任该公司与该交易有关的独家财务顾问。威尔逊·桑西尼·古德里奇和罗萨蒂律师事务所担任该公司的法律顾问。William Hood & Company, LLC担任Hiya的独家财务顾问。Bodman PLC担任Hiya的法律顾问。

Conference Call

电话会议

The Company will provide a supplemental presentation and discuss the transaction on a conference call on Monday, December 23, 2024 at 5:00 PM Eastern Time. The supplemental presentation and live audio webcast of the conference call will be available on the Company's investor relations website at .

该公司将在美国东部时间2024年12月23日星期一下午 5:00 的电话会议上提供补充演示并讨论该交易。电话会议的补充演示和网络直播将在公司的投资者关系网站上提供,网址为。

Non-GAAP Financial Measures

非公认会计准则财务指标

This press release contains the non-GAAP financial measure LTM adjusted EBITDA of Hiya. Adjusted EBITDA is a Non-GAAP financial measure of earnings before interest, taxes, depreciation, and amortization that also excludes certain adjustments as indicated below in the reconciliation from net income.

本新闻稿包含Hiya的非公认会计准则财务指标LtM调整后的息税折旧摊销前利润。调整后的息税折旧摊销前利润是衡量未计利息、税项、折旧和摊销前收益的非公认会计准则财务指标,其中还不包括净收益对账中如下文所示的某些调整。

The Company prepares its financial statements using U.S. generally accepted accounting principles ("GAAP") and investors should not directly compare with or infer relationship from any of the Company's operating results presented in accordance with GAAP to the LTM adjusted EBITDA of Hiya. We believe that this non-GAAP financial information of Hiya may be helpful to investors as an indication of future cash flow generation. Non-GAAP financial measures have limitations in their usefulness to investors because they have no standardized meaning prescribed by GAAP and are not prepared under any comprehensive set of accounting rules or principles. In addition, other companies, including companies in our industry, may calculate similarly titled non-GAAP financial measures differently or may use other measures to evaluate their performance, all of which could reduce the usefulness of non-GAAP financial information as a tool for comparison. As a result, the non-GAAP financial information of Hiya is presented for supplemental informational purposes only and should not be considered in isolation from, or as a substitute for financial information presented in accordance with GAAP.

公司使用美国公认会计原则(“GAAP”)编制财务报表,投资者不应直接将公司根据公认会计原则列报的任何经营业绩与Hiya的LtM调整后息税折旧摊销前利润进行比较或推断其关系。我们认为,Hiya的这些非公认会计准则财务信息可能会对投资者有所帮助,以此作为未来现金流产生的指标。非公认会计准则财务指标对投资者的用处有局限性,因为它们没有公认会计原则规定的标准化含义,也不是根据任何全面的会计规则或原则编制的。此外,其他公司,包括我们行业中的公司,可能会以不同的方式计算标题相似的非公认会计准则财务指标,或者可能使用其他衡量标准来评估其业绩,所有这些都可能降低非公认会计准则财务信息作为比较工具的用处。因此,Hiya的非公认会计准则财务信息仅供补充信息之用,不应与根据公认会计原则提供的财务信息分开考虑,也不能作为其替代品。

The following is a reconciliation of net income, presented and reported in accordance with GAAP, to Adjusted EBITDA:

以下是根据公认会计原则列报和报告的净收入与调整后息税折旧摊销前利润的对账情况:

(Unaudited)

Last Twelve Months Ended ($000's)

30-Sep-24

Net income

$

19,416

Definitional Adjustments:

Interest expense

143

Depreciation and amortization

38

Income tax expense

80

EBITDA before Adjustments

19,677

Adjustments to EBITDA:

Transaction expenses and other non-recurring items

760

Non-operational costs

566

Normalizations

321

Timing adjustments

212

Management compensation

142

Adjusted EBITDA

$

21,678

(未经审计)

最近十二个月已结束(000美元)

9 月 30 日至 24 日

净收入

$

19,416

定义调整:

利息支出

143

折旧和摊销

38

所得税支出

80

调整前的息税折旧摊销前利润

19,677

息税折旧摊销前利润调整:

交易费用和其他非经常性项目

760

非运营成本

566

正常化

321

时机调整

212

管理层薪酬

142

调整后 EBITDA

$

21,678

About USANA

关于 USANA

USANA develops and manufactures high-quality nutritional supplements, functional foods and personal care products that are sold directly to Associates and Preferred Customers throughout the United States, Canada, Australia, New Zealand, China, Japan, South Korea, Singapore, Mexico, Malaysia, the Philippines, the Netherlands, the United Kingdom, Thailand, France, Belgium, Colombia, Indonesia, Germany, Spain, Romania, Italy, and India. More information on USANA can be found at .

USANA开发和制造高质量的营养补充剂、功能性食品和个人护理产品,直接销售给美国、加拿大、澳大利亚、新西兰、中国、日本、韩国、新加坡、墨西哥、马来西亚、菲律宾、荷兰、英国、泰国、法国、比利时、哥伦比亚、印度尼西亚、德国、西班牙、罗马尼亚、意大利和印度的员工和优先客户。有关USANA的更多信息,请访问。

About Hiya

关于 Hiya

Hiya is the leading children's health brand, re-imagining kids' wellness with an inspired range of clean-label products. Offering a delicious and high-quality line of powders and chewables, Hiya is at the forefront of wellness with a focused assortment of better-for-you products. Since its founding in 2020, Hiya has established itself as a trusted name in the industry and is loved by both parents and children with adherence to the highest clean nutrition standards, ingredient transparency, and commitment to continuous improvement through ongoing collaborations with experts. More information on Hiya can be found at .

Hiya是领先的儿童健康品牌,通过一系列富有灵感的清洁标签产品重新构想孩子的健康。Hiya 提供一系列美味高品质的粉末和咀嚼片,站在健康的最前沿,提供种类齐全的更适合您的产品。自2020年成立以来,Hiya已确立了自己作为业内值得信赖的品牌的地位,并坚持最高的清洁营养标准,成分透明,并致力于通过与专家的持续合作进行持续改进,深受父母和孩子的喜爱。有关Hiya的更多信息,请访问。

Safe Harbor

安全港

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act, including but not limited to statements that: Hiya is fast growing; the Hiya acquisition will be accretive to USANA's 2025 adjusted EBITDA, experience net sales growth approaching 30% year-over-year in fiscal 2025, allow USANA to reach a broader audience, generate long-term growth, deliver value for USANA stakeholders, scale the Hiya brand, bring better health to children across the country and the world, enhance USANA's geographic sales mix and income tax efficiency in the near and long-term, take advantage of synergies, create efficiencies, accelerate growth and profitability, expand and diversify USANA's revenue mix, grow overall customer base, and strengthen USANA's overall financial profile; Mr. Litt and Mr. Gillman will continue to lead Hiya through its next phase of growth; Hiya will have a clear pathway and growth strategy to become the #1 children's wellness platform through new product introductions, channel expansion, and geographic expansion; and other forward-looking statements. These forward-looking statements are based on current plans, expectations, estimates, forecasts, and projections as well as the beliefs and assumptions of management. Words such as "expect," "vision," "envision," "evolving," "drive," "anticipate," "intend," "maintain," "should," "believe," "continue," "plan," "goal," "opportunity," "estimate," "predict," "may," "will," "could," and "would," and variations of these terms or the negative of these terms and similar expressions are intended to identify these forward-looking statements. Our actual results could differ materially from those projected in these forward-looking statements, which involve a number of risks and uncertainties, many of which involve factors or circumstances that are beyond our control, including: risks that the acquisition disrupts each company's current plans and operations; the diversion of the attention of the management teams of USANA and Hiya from ongoing business operations; the ability of to retain key personnel of Hiya; the ability to realize the benefits of the acquisition, including efficiencies and cost synergies; the ability to successfully integrate Hiya's business with USANA's business, at all or in a timely manner; the amount of the costs, fees, expenses and charges related to the acquisition; global economic conditions generally, including continued inflationary pressure around the world and negative impact on our operating costs, consumer demand and consumer behavior in general; reliance upon our network of independent Associates; risk that our Associate compensation plan, or changes that we make to the compensation plan, will not produce desired results, benefit our business or, in some cases, could harm our business; risk associated with governmental regulation of our products, manufacturing and direct selling business model in the United States, China and other key markets; potential negative effects of deteriorating foreign and/or trade relations between or among the United States, China and other key markets; potential negative effects from geopolitical relations and conflicts around the world, including the Russia-Ukraine conflict and the conflict in Israel; compliance with data privacy and security laws and regulations in our markets around the world; potential negative effects of material breaches of our information technology systems to the extent we experience a material breach; material failures of our information technology systems; adverse publicity risks globally; risks associated with commencing operations in India and future international expansion and operations; uncertainty relating to the fluctuation in U.S. and other international currencies; and the potential for a resurgence of COVID-19, or another pandemic, in any of our markets in the future and any related impact on consumer health, domestic and world economies, including any negative impact on discretionary spending, consumer demand, and consumer behavior in general. The contents of this release should be considered in conjunction with the risk factors, warnings, and cautionary statements that are contained in our most recent filings with the Securities and Exchange Commission. The forward-looking statements in this press release set forth our beliefs as of the date hereof. We do not undertake any obligation to update any forward-looking statement after the date hereof or to conform such statements to actual results or changes in the Company's expectations, except as required by law.

本新闻稿包含《证券法》第27A条和《证券交易法》第21E条所指的前瞻性陈述,包括但不限于以下陈述:Hiya正在快速增长;Hiya的收购将增加USANA2025年调整后的息税折旧摊销前利润,2025财年净销售额同比增长接近30%,使USANA能够吸引更广泛的受众,实现长期增长,为USANA利益相关者创造价值,扩大规模 Hiya品牌,为全国乃至全世界的儿童带来更好的健康,在短期和长期内提高USANA的地域销售组合和所得税效率,利用协同效应,创造效率,加速增长和盈利能力,扩大和分散USANA的收入组合,扩大整体客户群,加强USANA的整体财务状况;利特先生和吉尔曼先生将继续带领Hiya进入下一阶段的增长;Hiya将制定明确的路径和增长战略,通过新产品推出成为 #1 儿童健康平台、渠道扩张和地域扩张;及其他前瞻性陈述。这些前瞻性陈述基于当前的计划、预期、估计、预测和预测以及管理层的信念和假设。诸如 “期望”、“愿景”、“设想”、“发展”、“驱动”、“预测”、“打算”、“维持”、“应该”、“相信”、“继续”、“计划”、“目标”、“机会”、“估计”、“预测”、“可能” 和 “将” 之类的词语,以及这些术语的变体或其否定之处术语和类似表述旨在识别这些前瞻性陈述。我们的实际业绩可能与这些前瞻性陈述中的预测存在重大差异,其中涉及许多风险和不确定性,其中许多涉及我们无法控制的因素或情况,包括:收购干扰各公司当前计划和运营的风险;USANA和Hiya管理团队将注意力从正在进行的业务运营上转移开;留住Hiya关键人员的能力;实现收购收益的能力,包括效率和成本协同效应;将Hiya的业务完全或及时地成功整合到USANA业务中的能力;与收购相关的成本、费用、支出和收费金额;总体全球经济状况,包括全球持续的通货膨胀压力以及对我们运营成本、消费者需求和总体消费者行为的负面影响;对我们的独立员工网络的依赖;我们的员工薪酬计划或我们对薪酬计划进行修改的风险,不会产生预期的结果,使我们的业务受益,或者在某些情况下可能损害我们的业务;与美国、中国和其他主要市场的政府对我们的产品、制造和直销业务模式的监管相关的风险;美国、中国和其他主要市场之间或相互之间外交和/或贸易关系恶化的潜在负面影响;世界各地地缘政治关系和冲突,包括俄罗斯-乌克兰冲突和以色列冲突的潜在负面影响;遵守数据隐私和安全法律以及我们在全球市场的监管;我们的信息技术系统遭遇重大漏洞的潜在负面影响;我们的信息技术系统出现重大故障;全球负面宣传风险;与在印度开始运营以及未来国际扩张和运营相关的风险;与美国和其他国际货币波动相关的不确定性;以及未来任何市场可能出现的 COVID-19 或其他疫情卷土重来对消费者健康、国内和世界经济的相关影响,包括对全权支出、消费者需求和一般消费者行为的任何负面影响。本新闻稿的内容应与我们最近向美国证券交易委员会提交的文件中包含的风险因素、警告和警示声明一起考虑。本新闻稿中的前瞻性陈述阐述了我们截至发布之日的信念。除非法律要求,否则我们没有义务在本声明发布之日之后更新任何前瞻性陈述,也没有义务使此类陈述符合实际业绩或公司预期的变化。

View source version on businesswire.com:

在 businesswire.com 上查看源版本:

Investor contact:
Andrew Masuda
Investor Relations
(801) 954-7201
investor.relations@usanainc.com

投资者联系方式:
安德鲁增田
投资者关系
(801) 954-7201
investor.relations@usanainc.com

Media contact:
Sarah Searle
(801) 954-7626
media@usanainc.com

媒体联系人:
莎拉·塞尔
(801) 954-7626
media@usanainc.com

Source: USANA Health Sciences, Inc.

资料来源:USANA 健康科学公司

Released December 23, 2024

2024 年 12 月 23 日发布

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发